Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vir Biotechnology Inc (NQ: VIR )

9.350 +0.210 (+2.30%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,258,187
Open 9.160
Bid (Size) 9.050 (10)
Ask (Size) 9.340 (3)
Prev. Close 9.140
Today's Range 8.900 - 9.515
52wk Range 8.900 - 31.55
Shares Outstanding 133,976,538
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Thursday
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
What 8 Analyst Ratings Have To Say About Vir Biotechnology
Via Benzinga

Performance

YTD
-62.48%
-62.48%
1 Month
-27.24%
-27.24%
3 Month
-60.66%
-60.66%
6 Month
-59.37%
-59.37%
1 Year
-49.70%
-49.70%

More News

Read More
Is Vir Biotechnology Stock a Buy?
Via The Motley Fool
Earnings Scheduled For August 3, 2023
Via Benzinga
Where Vir Biotechnology Stands With Analysts
Via Benzinga
Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV
From Vir Biotechnology, Inc.
Via GlobeNewswire
Infectious Disease Player Vir Biotech Has Limited Near Term Upside, Analyst Downgrades
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
Via Benzinga
Why Vir Biotechnology Stock Is Plunging Today?
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Planet Labs PBC, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
From Vir Biotechnology, Inc.
Via GlobeNewswire
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
From Vir Biotechnology, Inc.
Via GlobeNewswire
Vir Biotechnology to Provide Business Update and Report Second Quarter 2023 Financial Results on August 3, 2023
From Vir Biotechnology, Inc.
Via GlobeNewswire
Microsoft, Snap, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Crude Oil Edges Higher; American Airlines Raises Profit Outlook
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Dow On Track For 9 Straight After Johnson & Johnson Earnings
Via Talk Markets
Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings
Via Benzinga
Why Shares of Vir Biotechnology Are Plunging Thursday
Via The Motley Fool
Nasdaq Down 50 Points; Tesla Earnings Beat Expectations
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.